SOLE (study of letrozole extension), a phase 3 randomized clinical trial of continuous vs intermittent letrozole in postmenopausal women who have received 4 6 years of adjuvant …

Guy Jerusalem,Subrina Farah,Jacquie Chirgwin,Stefan Aebi,Per Karlsson, Patrick Neven,Erika Hitre,Marie-Pascale Graas,Edda Simoncini,Claus Kamby, Alastair Thompson, Sibylle Loibl,Joaquin Gavila,Katsumasa Kuroi,Christian Marth,Bettina Mueller,Seamus O'Reilly,Andrea Gombos,Thomas Ruhstaller,Harold Burstein,Manuela Rabaglio,Barbara Ruepp, Giuseppe Viale, Richard D Gelber,Alan S Coates, Angelo Di Leo,Aron Goldhirsch,Meredith Regan,Marco Colleoni

CANCER RESEARCH（2020）

引用 0|浏览89

暂无评分

摘要

logo search. San Antonio Breast Cancer Symposium, Date: 2019/12/10 - 2019/12/14, Location: San Antonio, TX. Publication date: 2020-02. Volume: 80. ISSN: 0008-5472, 1538-7445. DOI: 10.1158/1538-7445.SABCS19-P5-12-01. Publisher: American Association for Cancer Research. CANCER RESEARCH. SOLE (study of letrozole extension), a phase 3 randomized clinical trial of continuous vs intermittent letrozole in postmenopausal women who have received 4-6 years of adjuvant endocrine therapy for lymph node-positive, early breast cancer (BC): Final analysis and sole estrogen substudy (SOLE-EST). Author: Jerusalem, Guy. Farah, Subrina ; Chirgwin, Jacquie ; Aebi, Stefan ; Karlsson, Per ; Neven, Patrick ; Hitre, Erika ; Graas, Marie-Pascale …

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要